Editorial · 8 min read
The Hidden Crisis in Elite Sports
One in eight elite athletes suffers from PTSD. Most will never tell you. The science now shows why. And it is not what you think.
Read the elite sports editorialTraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·TraumaTone · The world's first percutaneous bioelectronic implant for PTSD ·
Stimalia: Bioelectronic therapy for PTSD
“TraumaTone
quieting the body's alarm system.”
Upcoming events
European Neurotechnology Summit
Brussels (TheMerode)
Prototype on the demo table
Neurotech Leaders Forum
San Francisco
Company presentation
Brain Innovation Days
Brussels
Pitch Competition finalist
imec.istart Investor Day
Ghent (Wintercircus)
Investor pitch
HealthTech Investor Summit
Bruges
Selected to pitch
Incubated by the #1 university accelerator worldwide
Endorsed by the support for tech entrepreneurs
Incubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneurs
Endorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursIncubated by the #1 university accelerator worldwideEndorsed by the support for tech entrepreneursThe unmet need
001 / 00524M
Adults affected EU + US
50%
Treatment-resistant despite standard care
$350B
Annual societal cost
2.6×
More likely to be prescribed opioids
Veterans with PTSD, JAMA 2012
“PTSD is not a thought disorder. It is the body stuck in fight-or-flight.”
The approach
002 / 00501 · Targeted
The source, not the symptom
Modulates the stellate ganglion. It is the sympathetic system's central relay. Validated by a positive sham-controlled trial (JAMA Psychiatry, 2020).
02 · Minimally invasive
A single outpatient procedure
One percutaneous implantation. No daily pills. No repeated injections. Designed for durable, programmable benefit.
03 · Drug-free
No systemic exposure
The body's sympathetic alarm is calmed at its physiological origin, without pharmacological side effects.
Platform optionality
003 / 005One platform. Two species.
The technology behind TraumaTone is a platform, not a single product. The same percutaneous implant and the same anatomical target support a veterinary program, CalmTone Vet, addressing trauma related behavioural disorders in dogs. Two markets, one core technology, one shared clinical and regulatory foundation.
“Calm the alarm.
Restore the patient.”
Founders
004 / 005
Olivier Ménage, PharmD
CEO & Co-Founder
25+ years in medical devices across neuromodulation, minimally invasive surgery, and digital health. Founder of MONA.health. Former CEO at Man&Science.
Pascal Doguet, PhD
CTO & Co-Founder
25+ years pioneering neurostimulation R&D. Co-inventor on 300+ patent claims over his career in active implantable devices. Co-founder and former CTO of Synergia Medical.
Sylvain d'Amico, MSc
CCO & Co-Founder
25+ years in neurovascular and cardiovascular innovation at Boston Scientific, Edwards Lifesciences, Stryker and Penumbra.
“Today a procedure.
Tomorrow a therapy.”
Research & editorials
005 / 005
Research · 10 min read
Stellate Ganglion Block: A Paradigm Shift
What the evidence on stellate ganglion block for PTSD actually shows, and why a durable implant is the next step.
Read the stellate ganglion research
Editorial · 7 min read
PTSD in Military Populations
Why veterans and service members represent both the highest-need and highest-impact population for breakthrough PTSD interventions.
Read the military editorial“Restoring calm. Reclaiming lives.”
Receive scientific updates and milestones
Stimalia
Bioelectronic medicine · Louvain La Neuve · est. 2025